TrialSignal transduction and targeted therapy2021

Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial.

Huijie Bian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.